| CONTACTS: |
César García,
Chairman, President and CEO |
|
818-709-1244 x 7123
|
|
-or-
|
|
Ron Stabiner, The Wall Street Group, Inc. |
|
212-888-4848 |
CHATSWORTH, Calif., Mar 17, 2008 - IRIS International, Inc. (NASDAQ GM: IRIS)
a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief
Executive Officer César García will present a Company overview at the B. Riley & Co. 9th Annual Investor Conference at 9:00 a.m. (Pacific time) on Thursday,
April 3, 2008 at The Palms Resort Casino in Las Vegas.
THE COMPANY
IRIS International, Inc. (www.proiris.com), based in Chatsworth, Calif., is a leading developer,
manufacturer, and marketer of medical devices, diagnostic systems and consumables. The Iris Diagnostics Division (www.irisdiagnostics.com)
is a leader in automated urinalysis technology with systems in major medical institutions throughout the world. Iris Molecular Diagnostics develops innovative ultra-sensitive
diagnostics and sample processing products with applications in the urinalysis, oncology and infectious disease markets. The Company's Sample Processing business unit
(formerly the StatSpin® subsidiary) (www.statspin.com), based in Westwood, Mass., manufactures innovative
centrifuges and blood analysis products.
